Cardiovascular Comorbidities of Type 2 Diabetes Mellitus: Defining the Potential of Glucagonlike peptide–1-Based Therapies
Author:
Publisher
Elsevier BV
Subject
General Medicine
Reference225 articles.
1. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030;Wild;Diabetes Care,2004
2. A full accounting of diabetes and prediabetes in the U.S. population, 1988-1994 and 2005-2006;Cowie;Diabetes Care,2009
3. Diabetes prevalence and therapeutic target achievement in the United States, 1999-2006;Cheung;Am J Med,2009
4. Prevalence of overweight and obesity among adults with diagnosed diabetes—United States, 1988-1994 and 1999-2002;MMWR Morb Mortal Wkly Rep,2004
5. Impact of overweight on the risk of developing common chronic diseases during a 10-year period;Field;Arch Intern Med,2001
Cited by 59 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. GLP-1RA and SGLT2i: Cardiovascular Impact on Diabetic Patients;Current Hypertension Reviews;2021-11-05
2. Future perspectives in diabesity treatment: Semaglutide, a glucagon‑like peptide 1 receptor agonist (Review);Experimental and Therapeutic Medicine;2021-08-12
3. Effects of Exenatide on Coagulation and Platelet Aggregation in Patients with Type 2 Diabetes;Drug Design, Development and Therapy;2021-07
4. A 2021 Update on the Use of Liraglutide in the Modern Treatment of ‘Diabesity’: A Narrative Review;Medicina;2021-06-29
5. Comorbidities in type 2 diabetes patients with and without atherosclerotic cardiovascular disease: a retrospective database analysis;Current Medical Research and Opinion;2021-03-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3